MHRA approves first gene therapy for infusion into the brain
Upstaza™, approved for UK patients 18 months and over, is…
Upstaza™, approved for UK patients 18 months and over, is the first gene replacement therapy infused directly into the brain for the treatment of AADC deficiency.